Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1987 1
1989 2
1990 2
1991 1
1992 3
1993 4
1994 1
1995 5
1996 5
1997 1
1998 3
2005 1
2007 2
2011 2
2012 1
2015 1
2018 1
2019 2
2020 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders.
Windyga J, Guillet B, Rugeri L, Fournel A, Stefanska-Windyga E, Chamouard V, Pujol S, Henriet C, Bridey F, Négrier C. Windyga J, et al. Among authors: bridey f. Thromb Haemost. 2022 Aug;122(8):1304-1313. doi: 10.1055/a-1865-6978. Epub 2022 May 31. Thromb Haemost. 2022. PMID: 35642281 Free PMC article. Clinical Trial.
Activation of coagulation and fibrinolysis in heatstroke.
Bouchama A, Bridey F, Hammami MM, Lacombe C, al-Shail E, al-Ohali Y, Combe F, al-Sedairy S, de Prost D. Bouchama A, et al. Among authors: bridey f. Thromb Haemost. 1996 Dec;76(6):909-15. Thromb Haemost. 1996. PMID: 8972010
Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: Results from a prospective observational post-marketing study.
Goudemand J, Bridey F, Claeyssens S, Itzhar-Baïkian N, Harroche A, Desprez D, Négrier C, Chamouni P, Chambost H, Henriet C, Susen S, Borel-Derlon A. Goudemand J, et al. Among authors: bridey f. J Thromb Haemost. 2020 Aug;18(8):1922-1933. doi: 10.1111/jth.14928. Epub 2020 Jun 25. J Thromb Haemost. 2020. PMID: 32445594 Free PMC article.
Population pharmacokinetics of a triple-secured fibrinogen concentrate administered to afibrinogenaemic patients: Observed age- and body weight-related differences and consequences for dose adjustment in children.
Bellon A, Fuseau E, Roumanie O, Lamazure J, Stevens W, Dahmane A, Barthez-Toullec M, Golly D, Henriet C, Bridey F. Bellon A, et al. Among authors: bridey f. Br J Clin Pharmacol. 2020 Feb;86(2):329-337. doi: 10.1111/bcp.14147. Epub 2020 Jan 9. Br J Clin Pharmacol. 2020. PMID: 31658379 Free PMC article.
Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency.
Djambas Khayat C, El Khorassani M, Lambert T, Gay V, Barthez-Toullec M, Lamazure J, Bellon A, Henriet C, Bridey F, Négrier C. Djambas Khayat C, et al. Among authors: bridey f. J Thromb Haemost. 2019 Apr;17(4):635-644. doi: 10.1111/jth.14392. Epub 2019 Feb 20. J Thromb Haemost. 2019. PMID: 30661302 Free article. Clinical Trial.
43 results